Suppr超能文献

分子机制

Molecular mechanisms.

作者信息

Hebert S C

机构信息

Vanderbilt University Medical School, Division of Nephrology and Hypertension, Nashville, TN, USA.

出版信息

Semin Nephrol. 1999 Nov;19(6):504-23.

Abstract

The clinically useful and potent distal acting diuretics enhance urinary NaCl excretion by specific inhibition of distinct sodium transport processes in the loop of Henle and distal nephron. When these compounds were first used as diuretics little was known about their cellular mechanisms of action. Physiological investigations over the past 25 years, however, have shown that each class of diuretics inhibits a specific ion transport system in the kidney. Over the past few years, the molecular cloning of the distal diuretic-sensitive Na+ transporters has significantly enhanced our understanding of the mechanism of action of each class of diuretics and has clearly defined the specific protein (and its gene) that is the target for each of these diuretics. The identification of mutations in the genes encoding these transporters in inherited disorders characterized by alterations in salt balance has provided unequivocal evidence for roles of the cloned diuretic-sensitive transporters in sodium homeostasis. Many laboratories are actively engaged in defining the structural sites for ion transport and diuretic binding, and the molecular mechanisms of transport regulation. This information may enable the design of new diuretics and provide the basis for improved use of diuretics. This review will focus on this recent molecular information.

摘要

临床常用且强效的远端作用利尿剂通过特异性抑制髓袢升支粗段和远端肾单位中不同的钠转运过程来增加尿中氯化钠的排泄。当这些化合物最初被用作利尿剂时,人们对其细胞作用机制知之甚少。然而,过去25年的生理学研究表明,每一类利尿剂都抑制肾脏中的一种特定离子转运系统。在过去几年中,远端利尿剂敏感钠转运体的分子克隆显著增进了我们对每一类利尿剂作用机制的理解,并明确界定了这些利尿剂各自作用的特定蛋白质(及其基因)。在以盐平衡改变为特征的遗传性疾病中,编码这些转运体的基因突变的鉴定为克隆的利尿剂敏感转运体在钠稳态中的作用提供了明确证据。许多实验室正积极致力于确定离子转运和利尿剂结合的结构位点以及转运调节的分子机制。这些信息可能有助于设计新的利尿剂,并为更好地使用利尿剂提供依据。本综述将聚焦于这些最新的分子信息。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验